Valuation dashboard for The Cooper Companies, Inc. (COO) with P/E 20.32, P/B 1.38, EV/EBITDA 15.06 and dividend yield 0.00%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses.
Analysis Summary
The Cooper Companies, Inc. reported revenue of $4.09B in the most recent fiscal year, growing at a 5-year CAGR of 11.0%. Net income reached $374.9M, with a 9.5% 5-year CAGR.
Trailing-twelve-month margins: gross margin 63.6%, operating margin 12.9%, net margin 13.5%.
At $59.55 (closing price, October 30, 2026), COO trades at a P/E of 20.32 and an ROE of 6.88%. Market capitalisation stands at $11.3B, placing it among large-cap names.
Balance sheet quality for COO: current ratio of 1.9. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 20.32 |
| Price / Book | 1.38 |
| EV / EBITDA | 15.06 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $51.16 |
| vs Current Price | -14.1% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| COO | The Cooper Companies, Inc. | $11.3B | 20.32 | 1.38 | 6.9% |
| ALC | Alcon Inc. | $34.5B | 54.96 | 1.61 | 2.9% |
| GKOS | Glaukos Corporation | $14.1B | 19.58 | -24.9% | |
| BLCO | Bausch + Lomb Corporation | $7.1B | 1.11 | -1.7% | |
| ISRG | Intuitive Surgical, Inc. | $152.6B | 51.86 | 9.43 | 17.0% |
| 0R29.L | Intuitive Surgical, Inc. | $150.3B | 54.04 | 9.87 | 17.0% |
| 0R19.L | Becton, Dickinson and Company | $54.2B | 59.91 | 2.24 | 3.8% |
| BDX | Becton, Dickinson and Company | $53.9B | 59.60 | 2.23 | 3.8% |
Price
| Price | $59.55 (closing price, October 30, 2026) |
| Market Cap | $11.3B |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | 6.88% |
| Return on Invested Capital | 4.76% |
| Return on Assets | 4.50% |
| Gross Margin | 63.64% |
| Operating Margin | 12.85% |
| Net Margin | 13.46% |
Related companies: ALC · GKOS · BLCO · ISRG · 0R29.L · 0R19.L · BDX · 0KW4.L
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of COO: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks